Holen Sie sich die Stockscreener-App
9.74
4.70%
-0.48
Handel nachbörslich:
9.76
0.02
+0.21%
Schlusskurs vom Vortag:
$10.22
Offen:
$10.23
24-Stunden-Volumen:
437.92K
Relative Volume:
0.87
Marktkapitalisierung:
$456.75M
Einnahmen:
$502.79M
Nettoeinkommen (Verlust:
$23.71M
KGV:
19.48
EPS:
0.5
Netto-Cashflow:
$6.35M
1W Leistung:
-7.77%
1M Leistung:
-24.26%
6M Leistung:
-44.12%
1J Leistung:
-51.32%
1-Tages-Spanne:
$9.72
$10.30
1-Wochen-Bereich:
$9.72
$10.91
52-Wochen-Spanne:
$9.72
$21.83
Core Laboratories Inc Stock (CLB) Company Profile
Firmenname
Core Laboratories Inc
Sektor
Telefon
713-328-2673
Adresse
6316 WINDFERN ROAD, HOUSTON
Vergleichen Sie CLB mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
CLB
Core Laboratories Inc
|
9.74 | 479.26M | 502.79M | 23.71M | 6.35M | 0.50 |
|
SLB
Schlumberger Ltd
|
32.37 | 49.03B | 35.48B | 4.09B | 4.61B | 2.92 |
|
BKR
Baker Hughes Company
|
42.70 | 42.68B | 27.61B | 3.05B | 2.17B | 3.06 |
|
TS
Tenaris S A Adr
|
35.27 | 18.76B | 13.09B | 2.65B | 2.52B | 4.5936 |
|
HAL
Halliburton Co
|
20.50 | 17.82B | 22.56B | 2.10B | 2.34B | 2.39 |
|
FTI
Technipfmc Plc
|
34.97 | 14.37B | 9.27B | 827.80M | 1.24B | 1.90 |
Core Laboratories Inc Stock (CLB) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-03-12 | Hochstufung | Citigroup | Sell → Neutral |
| 2023-06-30 | Herabstufung | Citigroup | Neutral → Sell |
| 2023-04-18 | Herabstufung | BofA Securities | Neutral → Underperform |
| 2023-01-09 | Hochstufung | BofA Securities | Underperform → Neutral |
| 2022-10-07 | Hochstufung | Citigroup | Sell → Neutral |
| 2022-09-26 | Herabstufung | Morgan Stanley | Equal-Weight → Underweight |
| 2022-04-18 | Herabstufung | Piper Sandler | Neutral → Underweight |
| 2021-10-18 | Herabstufung | BofA Securities | Neutral → Underperform |
| 2021-07-09 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
| 2021-06-14 | Herabstufung | Citigroup | Neutral → Sell |
| 2020-12-18 | Herabstufung | JP Morgan | Neutral → Underweight |
| 2020-11-11 | Bestätigt | Cowen | Market Perform |
| 2020-10-13 | Hochstufung | BofA Securities | Underperform → Neutral |
| 2020-09-29 | Hochstufung | ABN Amro | Sell → Hold |
| 2020-07-16 | Herabstufung | Scotiabank | Sector Outperform → Sector Perform |
| 2020-04-13 | Hochstufung | Scotiabank | Sector Perform → Sector Outperform |
| 2020-03-09 | Herabstufung | BofA/Merrill | Buy → Underperform |
| 2020-03-09 | Herabstufung | Evercore ISI | Outperform → In-line |
| 2020-01-31 | Bestätigt | Cowen | Market Perform |
| 2020-01-30 | Fortgesetzt | Johnson Rice | Buy |
| 2020-01-14 | Eingeleitet | Bernstein | Mkt Perform |
| 2020-01-02 | Herabstufung | Stifel | Buy → Hold |
| 2019-12-31 | Bestätigt | Cowen | Market Perform |
| 2019-07-10 | Hochstufung | BofA/Merrill | Neutral → Buy |
| 2019-02-25 | Hochstufung | Tudor Pickering | Hold → Buy |
| 2018-12-19 | Herabstufung | Credit Suisse | Outperform → Neutral |
| 2018-12-11 | Herabstufung | JP Morgan | Overweight → Neutral |
| 2018-11-16 | Hochstufung | Guggenheim | Neutral → Buy |
| 2018-11-01 | Hochstufung | ABN Amro | Sell → Buy |
| 2018-10-29 | Bestätigt | Cowen | Market Perform |
Alle ansehen
Core Laboratories Inc Aktie (CLB) Neueste Nachrichten
Core Laboratories (CLB) Falls Amid a Difficult Time for the Oilfield Services Sector - MSN
Will Core Laboratories Inc. bounce back from current supportNeural Model for Stock Price Movement - Newser
Market reaction to Core Laboratories Inc.’s recent newsFree Weekly Return Pick Forecast Reports - Newser
Is Core Laboratories Inc. building a consolidation baseFree Target Return Focused Trade Insights - Newser
When is the best time to buy Core Laboratories Inc. stockDaily Swing Candidate Analysis with Chart Patterns - Newser
What MACD signals say about Core Laboratories Inc.Market Forecast Summary Over Multi-Year Period - Newser
What’s next for Core Laboratories Inc. stockEarnings Season Playbook - mustnews.co.kr
What is Core Laboratories Inc. s debt to equity ratioFree Volume Spike Tracker - classian.co.kr
Why Core Laboratories Inc. is moving todayFree Capital Preserving Trade Plan Templates - Newser
Can Core Laboratories Inc. rally from current levelsMomentum Detection with Entry Optimization - Newser
What analysts say about Core Laboratories Inc. stock outlookLow Risk Stock Selection Strategy Guide - Newser
Signal strength of Core Laboratories Inc. stock in tech scannersShort-Term Support and Resistance Forecast - Newser
Custom watchlist performance reports with Core Laboratories Inc.7-Day Equity Return Range Forecast Model - Newser
Reversal indicators forming on Core Laboratories Inc. stockFree Stock Selection With High Accuracy - Newser
Core Laboratories Dividend Details and Key Updates Before Ex-Dividend Date on Aug 4, 2025 - AInvest
How does Core Laboratories Inc. generate profit in a changing economyInvest smarter with actionable stock recommendations - Jammu Links News
When is Core Laboratories Inc. stock expected to show significant growthFree High-Return Strategy Alerts - Jammu Links News
How does Core Laboratories Inc. compare to its industry peersGet exclusive market insights for better trading - Jammu Links News
Is Core Laboratories Inc. stock overvalued or undervaluedGrow your wealth steadily and securely - Jammu Links News
Why is Core Laboratories Inc. stock attracting strong analyst attentionDiscover market opportunities with real-time data - Jammu Links News
How volatile is Core Laboratories Inc. stock compared to the marketNavigate the market with precision tools - Jammu Links News
What are the latest earnings results for Core Laboratories Inc.Get exclusive access to professional stock picks - Jammu Links News
Should I hold or sell Core Laboratories Inc. stock in 2025Market Forecast Signals For Fast Growth - Jammu Links News
Core Laboratories (NYSE:CLB) Shares Up 4.6%Still a Buy? - MarketBeat
Core Laboratories Inc. Breakout Confirmed by Volume MetricsAI Powered High Return Stock Calls Dominate Watchlists - metal.it
Here is Why Core Laboratories (CLB) Fell This Week - MSN
How many analysts rate Core Laboratories Inc. as a “Buy”Financial News Target Finder That Work - Jammu Links News
What recovery options are there for Core Laboratories Inc.Conservative Entry for High Return Setup Backed - metal.it
Core Laboratories (NYSE:CLB) Stock Rating Upgraded by Wall Street Zen - MarketBeat
Core Laboratories (NYSE:CLB) Trading Down 6.5%Here's What Happened - MarketBeat
How Core Laboratories Inc. stock performs during market volatilityHigh Accuracy Alerts for ROI Traders Detected - metal.it
Does Core Laboratories Inc. stock pay reliable dividendsAI Powered High Return Stock Calls Dominate Watchlists - metal.it
Core Laboratories Inc. to Issue Quarterly Dividend of $0.01 (NYSE:CLB) - MarketBeat
What makes Core Laboratories Inc. stock price move sharplyConfirmed Setup With Expert Accuracy Supported - metal.it
Core Laboratories (NYSE:CLB) Shares Gap Up After Strong Earnings - MarketBeat
What is the dividend policy of Core Laboratories Inc. stockDynamic capital growth - jammulinksnews.com
What is Core Laboratories Inc. company’s growth strategyTremendous wealth creation - jammulinksnews.com
Core Laboratories outlines Q3 2025 revenue guidance of $127.5M-$134.5M amid margin improvements and global expansion - MSN
Moving Average Trends for Core Laboratories Inc. Stock: What They Indicate Weekly Breakout Forecast with Entry Zones - beatles.ru
Core Laboratories (NYSE:CLB) Issues Q3 2025 Earnings Guidance - MarketBeat
Does Core Laboratories Inc. stock perform well during market downturnsOutstanding risk-reward balance - Jammu Links News
Finanzdaten der Core Laboratories Inc-Aktie (CLB)
Umsatz
Nettogewinn
Free Cashflow
ENV
Core Laboratories Inc-Aktie (CLB) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| Teo Sow Hang | CAO & Treasurer |
Aug 01 '25 |
Option Exercise |
0.00 |
440 |
0 |
7,840 |
| Teo Sow Hang | CAO & Treasurer |
May 01 '25 |
Option Exercise |
0.00 |
175 |
0 |
7,587 |
| Tattoli Mark Damian | SVP, Gen Counsel & Secretary |
May 01 '25 |
Option Exercise |
0.00 |
450 |
0 |
16,243 |
| Temeng Kwaku | Director |
Apr 01 '25 |
Option Exercise |
0.00 |
9,317 |
0 |
25,528 |
| Murray Katherine | Director |
Apr 01 '25 |
Option Exercise |
0.00 |
9,317 |
0 |
21,221 |
| Klingensmith Harvey Robert | Director |
Apr 01 '25 |
Option Exercise |
0.00 |
9,317 |
0 |
41,962 |
| Carnes Martha Z. | Director |
Apr 01 '25 |
Option Exercise |
0.00 |
9,317 |
0 |
46,328 |
| ANASTASIO CURT | Director |
Apr 01 '25 |
Option Exercise |
0.00 |
9,317 |
0 |
15,736 |
| Straughen Michael | Director |
Apr 01 '25 |
Option Exercise |
0.00 |
9,317 |
0 |
29,186 |
| Bruno Lawrence | Chairman and CEO |
Dec 31 '24 |
Option Exercise |
0.00 |
69,574 |
0 |
232,777 |
2.06%
1.59%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):